GANX vs HAS · $53.0M cap vs P/E 25, rev $2.40B
Gain Therapeutics Inc (GANX) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
GANX does not have a complete income-statement cache yet.
Latest reported HAS revenue for 2026-06-28 was $2.40B. Net income was $359.3M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
GANX currently screens at market cap $53.0M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the GANX and HAS stock pages for the full models.
Not investment advice.